novo nordisk glp 1 Nordisk's oral GLP-1 drug didn't work on Alzheimer's as hoped, but don't call it a failure Novo Nordisk Drops Hims &

Effets graves rapports en cas reports : priapisme ischmique (post 2 mg SC document), tachycardie svre, dilatation pupilles, sueurs, tremblements musculaires

Rehmannioside A attenuates cognitive deficits in rats with vascular dementia (VD) through suppressing oxidative stress, inflammation and apoptosis

[2] High-dose intramuscular administration creates a tissue depot that releases vitamin D slowly over weeks, potentially enabling a single injection to lift serum 25-hydroxyvitamin D levels into the sufficient range in severe deficiency and to potentially support bone mineralisation, neuromuscular function, and secondary hyperparathyroidism reversal while bypassing the gastrointestinal tract

The peptide may reduce lung inflammation, thereby enhancing collagen production and preventing fibrotic remodeling

It also may affect absorption of medication to treat hyperthyroidism